202 research outputs found
transcriptional regulation of nuclear genes controlling plastid differentiation in tomato
ABSTRACTSeveral mechanisms which control transcription of genes encoding plastidial proteins in tomato are overviewed: light, the circadian clock, photooxidative stress and tissue-specific factors. Protein factors binding promoters of genes responding to such stimuli are described, as well as their abundance during the various phases of the light-dark cycle. Finally, the structure and regulation of a novel class of genes encoding plastidial enzymes, controlling carotenoid biosynthesis, are describe
Colour preference of the deer ked Lipoptena fortisetosa (Diptera: Hippoboscidae)
SIMPLE SUMMARY: Insects use visual stimuli to find habitats, food, or a mate while moving around. This trait might be exploited to intercept flying insects to monitor their populations and reduce their presence. Among the various visual stimuli, colours are commonly used to attract insects. Lipoptena fortisetosa is a hematophagous deer ectoparasite native to Japan that has spread to several central European countries and was recently recorded in Italy. Measures to monitor and control L. fortisetosa would be helpful given its potential threat as a pathogen vector for animals and humans. The objective of this research was to assess the potential use of colour to attract and trap L. fortisetosa. The response of the winged adults was evaluated through an experimental trial carried out in a wooded area of Tuscany using differently coloured sticky panels as traps. Blue panels attracted the highest number while yellow panels showed the lowest performance. This preference for blue could be useful in the design of traps to reduce the population of this parasitic fly which, at certain times, can reach a very high density, causing annoyance to wildlife and humans visiting natural areas. ABSTRACT: Lipoptena fortisetosa, a deer ked native to Japan, has established itself in several European countries and was recently recorded in Italy. This hippoboscid ectoparasite can develop high density populations, causing annoyance to animals and concern regarding the potential risk of transmitting pathogens to humans. No monitoring or control methods for L. fortisetosa have been applied or tested up to now. This research evaluated the possible response of L. fortisetosa winged adults to different colours as the basis for a monitoring and control strategy. In the summer of 2020, a series of six differently coloured sticky panels were randomly set as traps in a wooded area used by deer for resting. The results indicated a clear preference of the deer ked for the blue panels that caught the highest number of flies during the experimental period. Lower numbers of flies were trapped on the red, green, black, and white panels, with the yellow panels recording the fewest captures. The response clearly demonstrates that this species displays a colour preference, and that coloured traps might be useful for monitoring and limiting this biting ectoparasite in natural areas harbouring wildlife and visited by people
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum
Tight coordination of gene expression in the developing cerebellum is crucial for establishment of neuronal circuits governing motor and cognitive function. However, transcriptional changes alone do not explain all of the switches underlying neuronal differentiation. Here we unveiled a widespread and highly dynamic splicing program that affects synaptic genes in cerebellar neurons. The motifs enriched in modulated exons implicated the splicing factor Sam68 as a regulator of this program. Sam68 controls splicing of exons with weak branchpoints by directly binding near the 3′ splice site and competing with U2AF recruitment. Ablation of Sam68 disrupts splicing regulation of synaptic genes associated with neurodevelopmental diseases and impairs synaptic connections and firing of Purkinje cells, resulting in motor coordination defects, ataxia, and abnormal social behavior. These findings uncover an unexpectedly dynamic splicing regulatory network that shapes the synapse in early life and establishes motor and cognitive circuitry in the developing cerebellum
Multiple Isoforms of Arabidopsis Casein Kinase I Combine Conserved Catalytic Domains with Variable Carboxyl-Terminal Extensions
Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C
Becker Muscular dystrophy (BMD) is an X-linked syndrome characterized by progressive muscle weakness. BMD is generally less severe than Duchenne Muscular Dystrophy. BMD is caused by mutations in the dystrophin gene that normally give rise to the production of a truncated but partially functional dystrophin protein. We generated an induced pluripotent cell line from dermal fibroblasts of a BMD patient carrying a splice mutation in the dystrophin gene (c.1705-8 T>C). The iPSC cell-line displayed the characteristic pluripotent-like morphology, expressed pluripotency markers, differentiated into cells of the three germ layers and had a normal karyotype
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is a debilitating fatal X-linked muscle disorder. Recent findings indicate that IGFs play a central role in skeletal muscle regeneration and development. Among IGFs, insulinlike growth factor 2 (IGF2) is a key regulator of cell growth, survival, migration and differentiation. The type 2 IGF receptor (IGF2R) modulates circulating and tissue levels of IGF2 by targeting it to lysosomes for degradation. We found that IGF2R and the store-operated Ca2+ channel CD20 share a common hydrophobic binding motif that stabilizes their association. Silencing CD20 decreased myoblast differentiation, whereas blockade of IGF2R increased proliferation and differentiation in myoblasts via the calmodulin/calcineurin/NFAT pathway. Remarkably, anti-IGF2R induced CD20 phosphorylation, leading to the activation of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) and removal of intracellular Ca2+. Interestingly, we found that IGF2R expression was increased in dystrophic skeletal muscle of human DMD patients and mdx mice. Blockade of IGF2R by neutralizing antibodies stimulated muscle regeneration, induced force recovery and normalized capillary architecture in dystrophic mdx mice representing an encouraging starting point for the development of new biological therapies for DMD
A Dynamic Splicing Program Ensures Proper Synaptic Connections in the Developing Cerebellum
Tight coordination of gene expression in the developing cerebellum is crucial for establishment of neuronal circuits governing motor and cognitive function. However, transcriptional changes alone do not explain all of the switches underlying neuronal differentiation. Here we unveiled a widespread and highly dynamic splicing program that affects synaptic genes in cerebellar neurons. The motifs enriched in modulated exons implicated the splicing factor Sam68 as a regulator of this program. Sam68 controls splicing of exons with weak branchpoints by directly binding near the 3′ splice site and competing with U2AF recruitment. Ablation of Sam68 disrupts splicing regulation of synaptic genes associated with neurodevelopmental diseases and impairs synaptic connections and firing of Purkinje cells, resulting in motor coordination defects, ataxia, and abnormal social behavior. These findings uncover an unexpectedly dynamic splicing regulatory network that shapes the synapse in early life and establishes motor and cognitive circuitry in the developing cerebellum
Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development
Clinical variability at the mild end of BRAT1-related spectrum: Evidence from two families with genotype–phenotype discordance
Biallelic mutations in the BRAT1 gene, encoding BRCA1-associated ATM activator 1, result in variable phenotypes, from rigidity and multifocal seizure syndrome, lethal neonatal to neurodevelopmental disorder, and cerebellar atrophy with or without seizures, without obvious genotype-phenotype associations. We describe two families at the mildest end of the spectrum, differing in clinical presentation despite a common genotype at the BRAT1 locus. Two siblings displayed nonprogressive congenital ataxia and shrunken cerebellum on magnetic resonance imaging. A third unrelated patient showed normal neurodevelopment, adolescence-onset seizures, and ataxia, shrunken cerebellum, and ultrastructural abnormalities on skin biopsy, representing the mildest form of NEDCAS hitherto described. Exome sequencing identified the c.638dup and the novel c.1395G>A BRAT1 variants, the latter causing exon 10 skippings. The p53-MCL test revealed normal ATM kinase activity. Our findings broaden the allelic and clinical spectrum of BRAT1-related disease, which should be suspected in presence of nonprogressive cerebellar signs, even without a neurodevelopmental disorder
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial.
Background: Nutritional compounds can exert both anti-inflammatory and anti-oxidant effects. Since these events exacerbate the pathophysiology of muscular dystrophies, we investigated nutraceutical supplementation as an adjuvant therapy in dystrophic patients, to low costs and easy route of administration. Moreover, this treatment could represent an alternative therapeutic strategy for dystrophic patients who do not respond to corticosteroid treatment.
Objective: A 24 weeks randomized double-blind placebo-controlled clinical study was aimed at evaluating the safety and efficacy of daily oral administration of flavonoidsand omega3-based natural supplement (FLAVOMEGA) in patients affected by muscular dystrophy with recognized muscle inflammation.
Design: We screened 60 patients diagnosed for Duchenne (DMD), Facioscapulohumeral (FSHD), and Limb Girdle Muscular Dystrophy (LGMD). Using a computer-generated random allocation sequence, we stratified patients in a 2:1:1 ratio (DMD:FSHD:LGMD) to one of two treatment groups: continuous FLAVOMEGA, continuous placebo. Of 29 patients included, only 24 completed the study: 15 were given FLAVOMEGA, 14 placebo.
Results: FLAVOMEGA was well tolerated with no reported adverse events. Significant treatment differences in the change from baseline in 6 min walk distance (6MWD; secondary efficacy endpoint) (P = 0.033) and in isokinetic knee extension (P = 0.039) (primary efficacy endpoint) were observed in LGMD and FSHD subjects. Serum CK levels (secondary efficacy endpoint) decreased in all FLAVOMEGA treated groups with significant difference in DMD subjects (P = 0.039).
Conclusions: Although the small number of patients and the wide range of disease severity among patients reduced statistical significance, we obtained an optimal profile of safety and tolerability for the compound, showing valuable data of efficacy in primary and secondary endpoints
- …